Recent studies into retatritide peptide demonstrate significant potential for treating obesity and non-insulin dependent disease. The peptide, a dual stimulator of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, seems to present improved weight reduction and glucose regulation versus existing treatments. Ongoing research e